These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 37631999)
1. Mutation Analysis of SARS-CoV-2 Variants Isolated from Symptomatic Cases from Andhra Pradesh, India. Nagaraja M; Sireesha K; Srikar A; Sudheer Kumar K; Mohan A; Vengamma B; Tirumala C; Verma A; Kalawat U Viruses; 2023 Jul; 15(8):. PubMed ID: 37631999 [TBL] [Abstract][Full Text] [Related]
2. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022. Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547 [TBL] [Abstract][Full Text] [Related]
3. Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China. Hussain B; Wu C Viruses; 2024 Jun; 16(6):. PubMed ID: 38932199 [TBL] [Abstract][Full Text] [Related]
4. Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India. Pal S; Mehta P; Pandey A; Ara A; Ghoshal U; Ghoshal UC; Pandey R; Tripathi RK; Yadav PN; Ravishankar R; Kundu TK; Rajender S Front Microbiol; 2023; 14():986729. PubMed ID: 36819024 [TBL] [Abstract][Full Text] [Related]
5. Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India. Misra G; Manzoor A; Chopra M; Upadhyay A; Katiyar A; Bhushan B; Anvikar A Sci Rep; 2023 Sep; 13(1):14847. PubMed ID: 37684328 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries. Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568 [TBL] [Abstract][Full Text] [Related]
7. Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India. Gopalan V; Chandran A; Arumugam K; Sundaram M; Velladurai S; Govindan K; Azhagesan N; Jeyavel P; Dhandapani P; Sivasubramanian S; Kitambi SS J Glob Infect Dis; 2023; 15(2):43-51. PubMed ID: 37469462 [TBL] [Abstract][Full Text] [Related]
8. Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India. Singh UB; Deb S; Rani L; Gupta R; Verma S; Kumari L; Bhardwaj D; Bala K; Ahmed J; Gaurav S; Perumalla S; Nizam M; Mishra A; Stephenraj J; Shukla J; Nayer J; Aggarwal P; Kabra M; Ahuja V; Chaudhry R; Sinha S; Guleria R J Biomol Struct Dyn; 2024 Jun; 42(9):4769-4781. PubMed ID: 37318006 [TBL] [Abstract][Full Text] [Related]
9. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing. Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043 [No Abstract] [Full Text] [Related]
10. A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India. Negi SS; Sharma K; Bhargava A; Singh P Arch Microbiol; 2024 Jan; 206(2):68. PubMed ID: 38238530 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 clade dynamics and their associations with hospitalisations during the first two years of the COVID-19 pandemic. Päll T; Abroi A; Avi R; Niglas H; Shablinskaja A; Pauskar M; Jõgeda EL; Soeorg H; Kallas E; Lahesaare A; Truusalu K; Hoidmets D; Sadikova O; Ratnik K; Sepp H; Dotsenko L; Epštein J; Suija H; Kaarna K; Smit S; Milani L; Metspalu M; Oopkaup OE; Koppel I; Jaaniso E; Kuzmin I; Inno H; Raudvere U; Härma MA; Naaber P; Reisberg T; Peterson H; Talas UG; Lutsar I; Huik K PLoS One; 2024; 19(5):e0303176. PubMed ID: 38728305 [TBL] [Abstract][Full Text] [Related]
12. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants. Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S Front Public Health; 2022; 10():1018399. PubMed ID: 36211690 [TBL] [Abstract][Full Text] [Related]
13. Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness. Ulzurrun E; Grande-Pérez A; Del Hoyo D; Guevara C; Gil C; Sorzano CO; Campillo NE Front Public Health; 2024; 12():1386596. PubMed ID: 39228849 [TBL] [Abstract][Full Text] [Related]
14. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study. Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954 [TBL] [Abstract][Full Text] [Related]
15. Omicron variant genome evolution and phylogenetics. Kandeel M; Mohamed MEM; Abd El-Lateef HM; Venugopala KN; El-Beltagi HS J Med Virol; 2022 Apr; 94(4):1627-1632. PubMed ID: 34888894 [TBL] [Abstract][Full Text] [Related]
16. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
17. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment. Kumar S; Karuppanan K; Subramaniam G J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610 [TBL] [Abstract][Full Text] [Related]
19. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic. Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226 [TBL] [Abstract][Full Text] [Related]
20. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses. Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]